$200,000 for the earliest ideas: two stomach-cancer researchers get seed grants to chase new tests and treatments

Stomach cancer receives less than 1% of federal cancer research money in the USA, so early ideas often stall before they can prove themselves. The Gastric Cancer Foundation has stepped into that gap with $200,000 in new seed grants. Andrew H. Song of MD Anderson Cancer Center receives $100,000 to develop an AI-driven technique that studies 3D images of stomach tissue and flags the growths most likely to turn cancerous. Kipp Weiskopf of Beth Israel Deaconess Medical Center receives $100,000 to develop a two-target antibody drug designed to attack stomach tumours. Since 2009, the foundation has awarded more than $4.7 million to early-stage stomach-cancer research.

SDG 3 · Good health and well-being — Mechanism: funding & finance